Oxaliplatin and Bolus-Modulated 5-Fluorouracil as a Second-Line Treatment for Advanced Pancreatic Cancer: Can Bolus Regimens Replace FOLFOX When Considered for Second Line?
Figure 1
(a) Progression-free survival; Kaplan-meier curves of both treatment regimens. (b) Overall survival; Kaplan-Meier curves of both treatment regimens.